cefotiam has been researched along with Escherichia coli Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, T; Hatano, K; Inoue, H; Kinoshita, T; Kinouchi, T; Kobayashi, M; Takada, T | 1 |
| Banks, SM; Cui, X; Eichacker, PQ; Gerstenberger, E; Hartung, T; Karzai, W; Mehlhorn, B; Natanson, C; Reinhart, K; Straube, E | 1 |
| Hasegawa, T; Hoshina, S; Hosoya, T; Ito, Y; Kawaguchi, Y; Kobayashi, A; Kono, M; Osaka, N; Utsunomiya, Y; Yamaguchi, Y; Yamamoto, I | 1 |
| Fujimura, M; Ito, F; Machida, H; Nakazawa, H; Ueno, E | 1 |
| Brion, N; Carbon, C; Joly, V; Pangon, B; Vallois, JM | 1 |
| Abel, L; Brion, N; Buré, A; Carbon, C; Contrepois, A; Joly, V; Pangon, B; Vallois, JM | 1 |
| Barbare, JC; Darchis, JP; Hercelin, B; Latrive, JP; Rosembaum, M | 1 |
7 other study(ies) available for cefotiam and Escherichia coli Infections
| Article | Year |
|---|---|
[Two cases of emphysematous pyelonephritis successfully treated by transurethral catheterization].
Topics: Aged, 80 and over; Cefotiam; Emphysema; Escherichia coli Infections; Female; Humans; Middle Aged; Pyelonephritis; Stents; Tomography, X-Ray Computed; Treatment Outcome; Urinary Catheterization | 2009 |
Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
Topics: Administration, Inhalation; Animals; Antibodies; Bronchoalveolar Lavage Fluid; Cefotiam; Cephalosporins; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Interleukin-6; Intubation, Intratracheal; Leukocyte Count; Lymphocyte Count; Male; Neutrophils; Oxygen; Oxygen Consumption; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Rats; Rats, Wistar; Sepsis; Staphylococcus aureus; Survival Analysis; Tumor Necrosis Factor-alpha | 2003 |
Malakoplakia of the kidney.
Topics: Anti-Bacterial Agents; Biopsy; Cefotiam; Diagnosis, Differential; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Japan; Kidney; Kidney Diseases; Malacoplakia; Male; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Spermatic cord abscess with concurrent prostatic abscess involving the seminal vesicle.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Cefotiam; Contrast Media; Diagnosis, Differential; Drainage; Escherichia coli Infections; Genital Diseases, Male; Hernia, Inguinal; Humans; Male; Pain; Prostate; Prostatic Diseases; Radiographic Image Enhancement; Rare Diseases; Seminal Vesicles; Spermatic Cord; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2008 |
Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
Topics: Animals; Cefmenoxime; Cefotaxime; Cefotiam; Ceftriaxone; Diclofenac; Drug Synergism; Endocarditis, Bacterial; Escherichia coli Infections; Injections, Intramuscular; Microbial Sensitivity Tests; Rabbits | 1988 |
Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
Topics: Animals; Cefmenoxime; Cefotaxime; Cefotiam; Ceftriaxone; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Escherichia coli; Escherichia coli Infections; Kinetics; Rabbits | 1987 |
[Course of the diffusion of cefotiam in infected ascitic fluid].
Topics: Adult; Aged; Ascitic Fluid; Bacterial Infections; Cefotaxime; Cefotiam; Diffusion; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Yersinia enterocolitica; Yersinia Infections | 1987 |